Generic-Drug Consumers Get Rare Boost With Ala. Ruling

Product Liability Law360, Reprinted with permission


Product Life Cycle and Class Actions + Mass Torts

In The News

In this article, James Huston comments on the Alabama Supreme Court's decision to uphold its controversial view that brand-name drug makers can be liable for inadequate warnings on generics marking the first such ruling by a state's highest court and endorsing a theory of misrepresentation that plaintiffs can now use to persuade other courts.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.